Rapid Micro Biosystems Inc Cash Flow Conversion Efficiency
Rapid Micro Biosystems Inc cash flow conversion efficiency. Based on the latest financial reports, Rapid Micro Biosystems Inc (RPID) has a cash flow conversion efficiency ratio of -0.716x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-12.70 Million) by net assets ($17.75 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Rapid Micro Biosystems Inc (2019–2025)
Cash flow conversion efficiency of Rapid Micro Biosystems Inc from 2019 to 2025. This chart illustrates how Rapid Micro Biosystems Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View RPID stock price for real-time trading data and today's change.
Rapid Micro Biosystems Inc Cash Flow Conversion Ratio Explained
Rapid Micro Biosystems Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Rapid Micro Biosystems Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Rapid Micro Biosystems Inc ranked by their cash flow conversion efficiency. Also see market cap of Rapid Micro Biosystems Inc for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Aeries Technology Inc.
NASDAQ:AERT
|
-1.835x |
|
Candles Scandinavia AB Series B
ST:CANDLE-B
|
-0.085x |
|
Kyung Chang Industrial Co. Ltd
KQ:024910
|
0.105x |
|
T S Flour Mill Public Company Limited
BK:TMILL
|
0.298x |
|
Woowon Development Co. Ltd
KQ:046940
|
0.063x |
|
New Advanced Electronics Technologies Co Ltd
TWO:3465
|
-0.107x |
|
S. Khonkaen Foods Public Company Limited
BK:SORKON
|
0.071x |
|
Kiattana Transport Public Company Limited
BK:KIAT
|
0.045x |
Annual Cash Flow Conversion Efficiency for Rapid Micro Biosystems Inc (2019–2025)
The table below shows the annual cash flow conversion efficiency of Rapid Micro Biosystems Inc from 2019 to 2025. Review Rapid Micro Biosystems Inc (RPID) flexibility index to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $33.21 Million | $-31.06 Million | -0.935x | -59.64% |
| 2024-12-31 | $75.35 Million | $-44.15 Million | -0.586x | -53.36% |
| 2023-12-31 | $117.99 Million | $-45.08 Million | -0.382x | -7.14% |
| 2022-12-31 | $164.17 Million | $-58.55 Million | -0.357x | -43.38% |
| 2021-12-31 | $220.98 Million | $-54.96 Million | -0.249x | +80.08% |
| 2020-12-31 | $24.82 Million | $-31.00 Million | -1.249x | -104.28% |
| 2019-12-31 | $-725.00K | $-21.15 Million | 29.168x | -- |
About Rapid Micro Biosystems Inc
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, … Read more